Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ONCOPROTEIN EXPRESSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 110 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jimenez, RE; Hussain, M; Bianco, FJ; Vaishampayan, U; Tabazcka, P; Sakr, WA; Pontes, JE; Wood, DP; Grignon, DJ
      Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors

      CLINICAL CANCER RESEARCH
    2. Fortin, A; Raybaud-Diogene, H; Tetu, B; Huot, J; Blondeau, L; Landry, J
      Markers of neck failure in oral cavity and oropharyngeal carcinomas treated with radiotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    3. Climent, MA; Segui, MA; Peiro, G; Molina, R; Lerma, E; Ojeda, B; Lopez-Lopez, JJ; Alonso, C
      Prognostic value of HER-23/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

      BREAST
    4. Cooke, T; Reeves, J; Lannigan, A; Stanton, P
      The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker

      EUROPEAN JOURNAL OF CANCER
    5. Yamauchi, H; Stearns, V; Hayes, DF
      When is a tumor marker ready for prime time? A case study of c-erbB-2 as apredictive factor in breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    6. Harris, LN; Liotcheva, V; Broadwater, G; Ramirez, MJ; Maimonis, P; Anderson, S; Everett, T; Harpole, D; Moore, MB; Berry, DA; Rizzeri, D; Vredenburgh, JJ; Bentley, RC
      Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    7. Assimakopoulou, M; Varakis, J
      AP-1 and heat shock protein 27 expression in human astrocytomas

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    8. Lewis, JE; Olsen, KD; Sebo, TJ
      Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases

      HUMAN PATHOLOGY
    9. Nio, Y; Dong, M; Iguchi, C; Yamasawa, K; Toga, T; Itakura, M; Tamura, K
      Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy

      JOURNAL OF SURGICAL ONCOLOGY
    10. Biroccio, A; Benassi, B; D'Agnano, I; D'Angelo, C; Buglioni, S; Mottolese, M; Ricciotti, A; Citro, G; Cosimelli, M; Ramsay, RG; Calabretta, B; Zupi, G
      c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer - Clinical and experimental findings

      AMERICAN JOURNAL OF PATHOLOGY
    11. Simon, R; Nocito, A; Hubscher, T; Bucher, C; Torhorst, J; Schraml, P; Bubendorf, L; Mihatsch, MM; Moch, H; Wilber, K; Schotzau, A; Kononen, J; Sauter, G
      Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    12. O'Malley, FP; Parkes, R; Latta, E; Tjan, S; Zadro, T; Mueller, R; Arneson, N; Blackstein, M; Andrulis, I
      Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

      AJCP. American journal of clinical pathology
    13. Kakar, S; Puangsuvan, N; Stevens, JM; Serenas, R; Mangan, G; Sahai, S; Mihalov, ML
      HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survival

      MOLECULAR DIAGNOSIS
    14. Ross, JS
      The HER-2/neu gene and protein in breast cancer: Methods of detection and clinical significance

      JOURNAL OF CLINICAL LIGAND ASSAY
    15. Ohmura, Y; Aoe, M; Andou, A; Shimizu, N
      Telomerase activity and Bcl-2 expression in non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    16. Moldvay, J; Scheid, P; Wild, P; Nabil, K; Siat, J; Borrelly, J; Marie, B; Farre, G; Labib, T; Pottier, G; Sesboue, R; Bronner, C; Vignaud, JM; Martinet, Y; Martinet, N
      Predictive survival markers in patients with surgically resected non-smallcell lung carcinoma

      CLINICAL CANCER RESEARCH
    17. Sahin, AA
      Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer

      ADVANCES IN ANATOMIC PATHOLOGY
    18. El-Naggar, AK; Callender, D; Coombes, MM; Hurr, K; Luna, MA; Batsakis, JG
      Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: A putative progression model?

      GENES CHROMOSOMES & CANCER
    19. Yazici, H; Dolapcioglu, K; Buyru, F; Dalay, N
      Utility of c-erbB-2 expression in tissue and sera of ovarian cancer patients

      CANCER INVESTIGATION
    20. Yazici, H; Altun, M; Alatli, C; Dogan, O; Dalay, N
      c-erbB-2 gene amplification in nasopharyngeal carcinoma

      CANCER INVESTIGATION
    21. Pich, A; Margaria, E; Chiusa, L
      Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival

      JOURNAL OF CLINICAL ONCOLOGY
    22. Nicholson, BP
      Ongoing and planned trials of hormonal therapy and trastuzumab

      SEMINARS IN ONCOLOGY
    23. Menard, S; Tagliabue, E; Campiglio, M; Pupa, SM
      Role of HER2 gene overexpression in breast carcinoma

      JOURNAL OF CELLULAR PHYSIOLOGY
    24. Manne, U; Weiss, HL; Grizzle, WE
      Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas

      INTERNATIONAL JOURNAL OF CANCER
    25. Konecny, G; Pegram, M; Untch, M; Thomssen, C; Janicke, F; Hepp, H; Slamon, DJ
      HER-2/neu as a predictive marker in breast cancer

      GEBURTSHILFE UND FRAUENHEILKUNDE
    26. Chan, WY; Cheung, KK; Schorge, JO; Huang, LW; Welch, WR; Bell, DA; Berkowitz, RS; Mok, SC
      Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers

      AMERICAN JOURNAL OF PATHOLOGY
    27. Marschitz, I; Tinhofer, I; Hittmair, A; Eagle, A; Kos, M; Greil, R
      Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia - A comparison of three semiquantitation techniques

      AJCP. American journal of clinical pathology
    28. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry - A study of interlaboratory agreement

      AJCP. American journal of clinical pathology
    29. Mai, KT; Yazdi, HM; Perkins, DG
      Mammary Paget's disease: Evidence of diverse origin of the disease with a subgroup of Paget's disease developing from the superficial portion of lactiferous duct and a discontinuous pattern of tumor spread

      PATHOLOGY INTERNATIONAL
    30. Bold, RJ; Hess, KR; Pearson, AS; Grau, AM; Sinicrope, FA; Jennings, M; McConkey, DJ; Bucana, CD; Cleary, KR; Hallin, PA; Chiao, PJ; Abbruzzese, JL; Evans, DB
      Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2

      JOURNAL OF GASTROINTESTINAL SURGERY
    31. Visca, P; Alo, PL; Del Nonno, F; Botti, C; Trombetta, G; Marandino, F; Filippi, S; Di Tondo, U; Donnorso, RP
      Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa

      CLINICAL CANCER RESEARCH
    32. Kayath, MJ; Martin, LC; Vieira, JGH; Nose, V
      C-erbB-2 immunoexpression in parathyroid tumors and hyperplasias

      ENDOCRINE PATHOLOGY
    33. Ross, JS; Fletcher, JA
      The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

      SEMINARS IN CANCER BIOLOGY
    34. Wu, YY; Khan, H; Chillar, R; Vadgama, JV
      Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    35. Hanna, W; Kahn, HJ; Trudeau, M
      Evaluation of HER-2/neu (erbB-2) status in breast cancer: From bench to bedside

      MODERN PATHOLOGY
    36. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    37. Pandha, HS; Martin, LA; Rigg, A; Hurst, HC; Stamp, GWH; Sikora, K; Lemoine, NR
      Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression

      JOURNAL OF CLINICAL ONCOLOGY
    38. Valentini, AM; Caruso, ML; Armentano, R; Pirrelli, M; Rizzi, E; Lapenna, F; Renna, L
      Programmed cell death in colorectal carcinogenesis

      ANTICANCER RESEARCH
    39. Yang, HB; Chow, NH; Sheu, BS; Chan, SH; Chien, CH; Su, IJ
      The role of bcl-2 in the progression of the colorectal adenoma carcinoma sequence

      ANTICANCER RESEARCH
    40. Fu, XL; Zhu, XZ; Shi, DR; Xiu, LZ; Wang, LJ; Zhao, S; Qian, H; Lu, HF; Xiang, YB; Jiang, GL
      Study of prognostic predictors for non-small cell lung cancer

      LUNG CANCER
    41. Mitchell, MS; Press, MF
      The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer

      SEMINARS IN ONCOLOGY
    42. Ravdin, PM
      Should HER2 status be routinely measured for all breast cancer patients?

      SEMINARS IN ONCOLOGY
    43. Rudolph, P; Olsson, H; Bonatz, G; Ratjen, V; Bolte, H; Baldetorp, B; Ferno, M; Parwaresch, R; Alm, P
      Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negativebreast carcinomas: Prognostic implications

      JOURNAL OF PATHOLOGY
    44. Takata, M; Fujimoto, A; Aoki, H; Hatta, N; Ooi, A; Takehara, K
      erbB-2 overexpression but no activation of beta-catenin gene in extramammary Paget's disease

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    45. Jaattela, M
      Escaping cell death: Survival proteins in cancer

      EXPERIMENTAL CELL RESEARCH
    46. Depowski, PL; Brien, TP; Sheehan, CE; Stylos, S; Johnson, RL; Ross, JS
      Prognostic significance of p34(cdc2) cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer

      AJCP. American journal of clinical pathology
    47. Ross, JS; Fletcher, JA
      HER-2/neu (c-erb-B2) gene and protein in breast cancer

      AJCP. American journal of clinical pathology
    48. Ross, JS; Yang, F; Kallakury, BVS; Sheehan, CE; Ambros, RA; Muraca, PJ
      HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary

      AJCP. American journal of clinical pathology
    49. Kanitakis, J
      Immunohistochemistry of normal human skin

      EUROPEAN JOURNAL OF DERMATOLOGY
    50. ROSS JS; FLETCHER JA
      THE HER-2 NEU ONCOGENE IN BREAST-CANCER - PROGNOSTIC FACTOR, PREDICTIVE FACTOR, AND TARGET FOR THERAPY/

      Stem cells
    51. OZTURK M; BOLKENT S; YILMAZER S; KANER G; UNAL H
      DETECTION OF C-ERBB-2 MESSENGER-RNAS USING DIG-LABELED OLIGONUCLEOTIDE PROBE WITH IN-SITU HYBRIDIZATION IN HUMAN BREAST-CARCINOMA - COMPARISON WITH IMMUNOHISTOCHEMICAL RESULTS

      Analytical cellular pathology
    52. ALLRED DC; HARVEY JM; BERARDO M; CLARK GM
      PROGNOSTIC AND PREDICTIVE FACTORS IN BREAST-CANCER BY IMMUNOHISTOCHEMICAL ANALYSIS

      Modern pathology
    53. DZIADZIUSZKO R; JASSEM E; JASSEM J
      CLINICAL IMPLICATIONS OF MOLECULAR ABNORMALITIES IN LUNG-CANCER

      Cancer treatment reviews
    54. SINGH A; TONG A; OGNOSKIE N; MEYER W; NEMUNAITIS J
      IMPROVED SURVIVAL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA FAILING 5-FLUOROURACIL WHO RECEIVED IRINOTECAN HYDROCHLORIDE AND HAVE HIGHINTRATUMOR C-FOS EXPRESSION

      American journal of clinical oncology
    55. Muller, W; Schneiders, A; Hommel, G; Gabbert, HE
      Prognostic value of bcl-2 expression in gastric cancer

      ANTICANCER RESEARCH
    56. ORTIZHIDALGO C; DELAVEGA G; AGUIRREGARCIA J
      THE HISTOPATHOLOGY AND BIOLOGIC PROGNOSTIC FACTORS OF BARRETTS-ESOPHAGUS - A REVIEW

      Journal of clinical gastroenterology
    57. ABEND M; VANBEUNINGEN D
      SIGNIFICANCE OF APOPTOSIS FOR RADIOTHERAPY - PART II

      Strahlentherapie und Onkologie
    58. Pegram, MD; Pauletti, G; Slamon, DJ
      HER-2/neu as a predictive marker of response to breast cancer therapy

      BREAST CANCER RESEARCH AND TREATMENT
    59. Henderson, IC; Patek, AJ
      The relationship between prognostic and predictive factors in the management of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    60. KANITAKIS J; FAURE M; CLAUDY A
      IMMUNOHISTOCHEMISTRY FOR THE DIAGNOSIS OF SKIN TUMORS

      Annales de dermatologie et de venereologie
    61. VERMEULEN C; BOUGEROL O; SIBLANI Y
      PERIANAL PAGETS-DISEASE - REPORT OF A CAS E AND REVIEW OF THE LITERATURE

      La Semaine des hopitaux de Paris
    62. OSAKO T; MIYAHARA M; UCHINO S; INOMATA M; KITANO S; KOBAYASHI M
      IMMUNOHISTOCHEMICAL STUDY OF C-ERBB-2 PROTEIN IN COLORECTAL-CANCER AND THE CORRELATION WITH PATIENT SURVIVAL

      Oncology
    63. FEHM T; MAIMONIS P; KATALINIC A; JAGER WH
      THE PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 SERUM-PROTEIN IN METASTATIC BREAST-CANCER

      Oncology
    64. GUDDO F; GIATROMANOLAKI A; KOUKOURAKIS MI; REINA C; VIGNOLA AM; CHLOUVERAKIS G; HILKENS J; GATTER KC; HARRIS AL; BONSIGNORE G
      MUC1 (EPISIALIN) EXPRESSION IN NONSMALL CELL LUNG-CANCER IS INDEPENDENT OF EGFR AND C-ERBB-2 EXPRESSION AND CORRELATES WITH POOR SURVIVAL IN NODE-POSITIVE PATIENTS

      Journal of Clinical Pathology
    65. VOLLMER RT; HUMPHREY PA; SWANSON PE; WICK MR; HUDSON MA
      INVASION OF THE BLADDER BY TRANSITIONAL-CELL CARCINOMA - ITS RELATIONTO HISTOLOGIC GRADE AND EXPRESSION OF P53, MIB-1, C-ERB B-2, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND BCL-2

      Cancer
    66. ALLRED DC; HILSENBECK SG
      BIOMARKERS IN BENIGN BREAST DISEASE - RISK-FACTORS FOR BREAST-CANCER

      Journal of the National Cancer Institute
    67. ROHAN TE; HARTWICK W; MILLER AB; KANDEL RA
      IMMUNOHISTOCHEMICAL DETECTION OF C-ERBB-2 AND P53 IN BENIGN BREAST DISEASE AND BREAST-CANCER RISK

      Journal of the National Cancer Institute
    68. METERISSIAN SH
      APOPTOSIS - ITS ROLE IN THE PROGRESSION OF AND CHEMOTHERAPY FOR CARCINOMA

      Journal of the American College of Surgeons
    69. NORDGARD S; FRANZEN G; BOYSEN M; HALVORSEN TB
      P53 PROTEIN EXPRESSION IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK - CORRELATION WITH PROLIFERATIVE ACTIVITY AND CLINICOPATHOLOGICAL PARAMETERS

      Oncology Reports
    70. STAL O; KLINTENBERG C; SULLIVAN S
      OVEREXPRESSION OF C-ERBB-2 PROTEIN AND LOCOREGIONAL RECURRENCE IN NODE-POSITIVE BREAST-CANCER

      Breast
    71. RAYBAUDDIOGENE H; FORTIN A; MORENCY R; ROY J; MONTEIL RA; TETU B
      MARKERS OF RADIORESISTANCE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY

      Journal of clinical oncology
    72. CHEUNG TH; LEUNG JO; CHUNG TKH; LAM SK; TO KF; WONG YF
      C-FOS OVEREXPRESSION IS ASSOCIATED WITH THE PATHONEOGENESIS OF INVASIVE CERVICAL-CANCER

      Gynecologic and obstetric investigation
    73. WILLSHER PC; LEACH LH; ELLIS IO; BELL JA; ELSTON CW; BOURKE JB; BLAMEY RW; ROBERTSON JFR
      MALE BREAST-CANCER - PATHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES

      Anticancer research
    74. FEHM T; MAIMONIS P; WEITZ S; TERAMOTO Y; KATALINIC A; JAGER W
      INFLUENCE OF CIRCULATING C-ERBB-2 SERUM-PROTEIN ON RESPONSE TO ADJUVANT CHEMOTHERAPY IN NODE-POSITIVE BREAST-CANCER PATIENTS

      Breast cancer research and treatment
    75. WANG DG; JOHNSTON CF; BUCHANAN KD
      ONCOGENE EXPRESSION IN GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS -IMPLICATIONS FOR PATHOGENESIS

      Cancer
    76. NAKANO T; OKA K; ISHIKAWA A; MORITA S
      CORRELATION OF CERVICAL-CARCINOMA C-ERB B-2 ONCOGENE WITH CELL-PROLIFERATION PARAMETERS IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CERVICAL-CARCINOMA

      Cancer
    77. TAKATA M; HATTA N; TAKEHARA K
      TUMOR-CELLS OF EXTRAMAMMARY PAGETS-DISEASE DO NOT SHOW EITHER P53 MUTATION OR ALLELIC LOSS AT SEVERAL SELECTED LOCI IMPLICATED IN OTHER CANCERS

      British Journal of Cancer
    78. RAMACHANDRA S; GILLETT CE; MILLIS RR
      A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY OF MAMMARY AND EXTRAMAMMARY PAGETS-DISEASE AND SUPERFICIAL SPREADING MELANOMA, WITH PARTICULAR EMPHASIS ON MELANOCYTIC MARKERS

      Virchows Archiv
    79. CARLOMAGNO C; PERRONE F; GALLO C; DELAURENTIIS M; LAURIA R; MORABITO A; PETTINATO G; PANICO L; DANTONIO A; BIANCO AR; DEPLACIDO S
      C-ERBB2 OVEREXPRESSION DECREASES THE BENEFIT OF ADJUVANT TAMOXIFEN INEARLY-STAGE BREAST-CANCER WITHOUT AXILLARY LYMPH-NODE METASTASES

      Journal of clinical oncology
    80. BAST RC; BATES S; BREDT AB; DESCH CE; FRITSCHE H; FUES L; HAYES DF; KEMENY NE; KRAGEN M; JESSUP J; LOCKER GY; MACDONALD JS; MENNEL RG; NORTON L; RAVDIN P; SMITH TJ; TAUBE S; WINN RJ
      CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER

      Journal of clinical oncology
    81. YAZICI H; MUSLUMANOGLU M; GUZEY D; YASASEVER V; OZBEK U; DALAY N
      AMPLIFICATION IN TUMORS AND BENIGN TISSUE OF BREAST-CANCER PATIENTS

      Cancer letters
    82. TERRIER P; MOURIESSE H; LORIDON B; GOTTELAND M; MAYLEVIN F; DELARUE JC
      USE OF A POLYCLONAL ANTIBODY FOR THE DETERMINATION OF THE PROGNOSTIC VALUE OF C-ERBB-2 PROTEIN OVER-EXPRESSION IN HUMAN BREAST-CANCER

      Acta oncologica
    83. VOGEL W; KATH R; KOSMEHL H; OLSCHOWSKY E
      THE NEU ONCOGENE PRODUCT IN SERUM AND TISSUE OF PATIENTS WITH METASTATIC GASTROINTESTINAL CARCINOMAS

      Journal of cancer research and clinical oncology
    84. YAMAMOTO Y; KISHIMOTO Y; VIRMANI AK; SMITH A; VUITCH F; ALBORESSAAVEDRA J; GAZDAR AF
      MUTATIONS ASSOCIATED WITH CARCINOMAS ARISING FROM PLEOMORPHIC ADENOMAS OF THE SALIVARY-GLANDS

      Human pathology
    85. RAJKUMAR T; STAMP GWH; PANDHA HS; WAXMAN J; GULLICK WJ
      EXPRESSION OF THE TYPE-1 TYROSINE KINASE GROWTH-FACTOR RECEPTORS EGF RECEPTOR, C-ERBB2 AND C-ERBB3 IN BLADDER-CANCER

      Journal of pathology
    86. MOLLAND JG; BARRACLOUGH BH; GEBSKI V; MILLIKEN J; BILOUS M
      PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 ONCOGENE IN AXILLARY NODE-NEGATIVE BREAST-CANCER

      Australian and New Zealand journal of surgery
    87. LUPU R; CARDILLO M; HARRIS L; HIJAZI M; ROSENBERG K
      INTERACTION BETWEEN ERBB- RECEPTORS AND HEREGULIN IN BREAST-CANCER TUMOR PROGRESSION AND DRUG-RESISTANCE

      Seminars in cancer biology
    88. STAL O; SULLIVAN S; WINGREN S; SKOOG L; RUTQVIST LE; CARSTENSEN JM; NORDENSKJOLD B
      C-ERBB-2 EXPRESSION AND BENEFIT FROM ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY OF BREAST-CANCER

      European journal of cancer
    89. DEPOTTER CR; SCHELFHOUT AM
      THE NEU-PROTEIN AND BREAST-CANCER

      Virchows Archiv
    90. WEBB A; SCOTTMACKIE P; CUNNINGHAM D; NORMAN A; ANDREYEV J; OBRIEN M; BENSTED J
      THE PROGNOSTIC VALUE OF CEA, BETA-HCG, AFP, CA125, CA19-9 AND C-ERB B-2, BETA-HCG IMMUNOHISTOCHEMISTRY IN ADVANCED COLORECTAL-CANCER

      Annals of oncology
    91. GORGOULIS VG; BARBATIS C; POULIAS I; KARAMERIS AM
      MOLECULAR AND IMMUNOHISTOCHEMICAL EVALUATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERB-B-2 GENE-PRODUCT IN TRANSITIONAL-CELL CARCINOMASOF THE URINARY-BLADDER - A STUDY IN GREEK PATIENTS

      Modern pathology
    92. RAVDIN PM; CHAMNESS GC
      THE C-ERBB-2 PROTOONCOGENE AS A PROGNOSTIC AND PREDICTIVE MARKER IN BREAST-CANCER - A PARADIGM FOR THE DEVELOPMENT OF OTHER MACROMOLECULAR MARKERS - A REVIEW

      Gene
    93. BROTHERICK I; SHENTON BK; COWAN WK; ANGUS B; HORNE CHW; HIGGS MJ; LENNARD TWJ
      RELATIONSHIP BETWEEN FLOW-CYTOMETRIC AND IMMUNOHISTOCHEMICALLY DETECTED C-ERBB-2 EXPRESSION, GRADE AND DNA-PLOIDY IN BREAST-CANCER

      Cancer immunology and immunotherapy
    94. SCHONBORN I; ZSCHIESCHE W; MINGUILLON C; SPITZER E; MOHNER M; EBELING K; GROSSE R
      PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN AND C-ERBB-2 COMPARED WITH CONVENTIONAL HISTOPATHOLOGICAL FACTORS IN BREAST-CANCER

      Journal of cancer research and clinical oncology
    95. QUENEL N; WAFFLART J; BONICHON F; DEMASCAREL I; TROJANI M; DURAND M; AVRIL A; COINDRE JM
      THE PROGNOSTIC VALUE OF C-ERBB2 IN PRIMARY BREAST CARCINOMAS - A STUDY ON 942 CASES

      Breast cancer research and treatment
    96. MITTRA I; REDKAR AA; BADWE RA
      PROGNOSIS OF BREAST-CANCER - EVIDENCE FOR INTERACTION BETWEEN C-ERBB-2 OVEREXPRESSION AND NUMBER OF INVOLVED AXILLARY LYMPH-NODES

      Journal of surgical oncology
    97. DIGIOVANNA MP; STERN DF
      ACTIVATION STATE-SPECIFIC MONOCLONAL-ANTIBODY DETECTS TYROSINE-PHOSPHORYLATED P185(NEU ERBB-2) IN A SUBSET OF HUMAN BREAST-TUMORS OVEREXPRESSING THIS RECEPTOR/

      Cancer research
    98. NOGUCHI M; MIZUKAMI Y; KINOSHITA K; EARASHI M; THOMAS M; MIYAZAKI I
      EXPRESSION OF C-ERBB-2 AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CARCINOMA - PROGNOSTIC VALUE AND CORRELATION WITH CLINICOPATHOLOGICALAND BIOLOGICAL VARIABLES

      Oncology Reports
    99. GORGOULIS V; TSATSANIS C; OZANNE B; SPANDIDOS DA
      DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB-2 GENE AMPLIFICATION IN TRANSITIONAL-CELL BLADDER-CARCINOMA USING THE DIFFERENTIALPCR TECHNIQUE

      International journal of oncology
    100. NOGUCHI M; MIZUKAMI Y; KINOSHITA K; EARASHI M; THOMAS M; MIYAZAKI I
      C-ERBB-2, RAS P21, AND C-MYC EXPRESSION IN BREAST-CARCINOMA - PROGNOSTIC VALUE AND CORRELATION WITH CLINICOPATHOLOGICAL AND BIOLOGIC VARIABLES

      International journal of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 11:57:31